EUVIMEDEUVIMED entdecken
FallberichtLeserbrief

Pediatric erythroblastic transformation of JAK 2‐mutated prefibrotic primary myelofibrosis with concurrent PHF6 mutations

Tokiko Oshiro, Satoru Hamada iD, Sinobu Kiyuna, Hideki Sakiyama, Nobuyuki Hyakuna, Tomoko Tamaki, Hideki Muramatsu, Koichi Nakanishi

Pediatric Blood & Cancer · 2023

DOI: 10.1002/pbc.30508 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Pediatric Blood & Cancer, 2023. Verfasst von Tokiko Oshiro und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, University of Ryukyus Hospital, Nakagami-gun, Japan. Hauptthemen laut MEDLINE: Primary Myelofibrosis. Die Arbeit nennt 11 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Primary MyelofibrosisHumansBone MarrowCalreticulinJanus Kinase 2MutationRepressor ProteinsMaleAdolescent

Substanzen

CalreticulinJAK2 protein, humanJanus Kinase 2PHF6 protein, humanRepressor Proteins

Autor:innen und Institutionen

  • Department of Pediatrics, University of Ryukyus Hospital, Nakagami-gun, Japan.
  • Okinawa Prefectural Red Cross Blood Center, Naha, Japan.
  • Department of Pathology and Oncology, Graduate School of Medicine, University of Ryukyus, Nakagami-gun, Japan.
  • Department of Pediatrics, Graduate School of Medicine, University of Nagoya, Nagoya, Japan.
  • Department of Pediatrics, Graduate School of Medicine, University of The Ryukyus, Nakagami-gun, Japan.

ORCID-Profile: Satoru Hamada

Zitieren

APA

Oshiro, T., Hamada, S., Kiyuna, S., Sakiyama, H., Hyakuna, N., Tamaki, T., Muramatsu, H., & Nakanishi, K. (2023). Pediatric erythroblastic transformation of JAK 2‐mutated prefibrotic primary myelofibrosis with concurrent PHF6 mutations. Pediatric Blood & Cancer. https://doi.org/10.1002/pbc.30508

Vancouver

Oshiro T, Hamada S, Kiyuna S, Sakiyama H, Hyakuna N, Tamaki T, et al. Pediatric erythroblastic transformation of JAK 2‐mutated prefibrotic primary myelofibrosis with concurrent PHF6 mutations. Pediatric Blood & Cancer. 2023. doi:10.1002/pbc.30508

BibTeX
@article{Oshiro2023,
  author = {Oshiro, Tokiko and Hamada, Satoru and Kiyuna, Sinobu and Sakiyama, Hideki and Hyakuna, Nobuyuki and Tamaki, Tomoko and Muramatsu, Hideki and Nakanishi, Koichi},
  title = {Pediatric erythroblastic transformation of JAK 2‐mutated prefibrotic primary myelofibrosis with concurrent PHF6 mutations},
  journal = {Pediatric Blood & Cancer},
  year = {2023},
  doi = {10.1002/pbc.30508}
}
Kostenlos starten →